Intermittent Ozempic shortages are expected throughout 2024, while Victoza shortages are expected at least until the second quarter of 2024
For Victoza, shortages are expected at least until Q2 2024. The supply shortage is not related to a quality defect of the products or a safety
It is stated in the letter that, for Ozempic, intermittent shortages are expected throughout 2024. For Victoza, shortages are expected at least
The shortage situation for Ozempic and Victoza will deteriorate in Q4 2024. For Ozempic, intermittent shortages are expected throughout 2024. For Victoza, shortages are expected at least until Q2 2024. The supply shortages are not related to a quality defect of the products or a safety issue.
Ozempic, Novo Nordisk decided to temporarily reduce the supply of Victoza . The shortage situation for Ozempic and Victoza will deteriorate in Q4 2024. For Ozempic, intermittent shortages are expected throughout 2024. For Victoza, shortages are expected at least until Q2 2024. The supply shortage is not related to a quality defect of the
As of July 2024, Ozempic and Victoza are listed on the European Medicines Agency's drug shortages list,13 and Ozempic, Victoza and Mounjaro are
For Victoza, shortages are expected at least until Q2 2024. The supply shortage is not related to a quality defect of the products or a safety
Intermittent Ozempic shortages are expected throughout 2024, while Victoza shortages are expected at least until the second quarter of 2024
For Victoza, shortages are expected at least until Q2 2024. The supply shortage is not related to a quality defect of the products or a safety
Comments